
Becton, Dickinson and Company owns 1 brand in our database. Browse the complete portfolio of Becton, Dickinson and Company subsidiaries and brands across various industries.
Company Type
public
Headquarters
Franklin Lakes, New Jersey, USA
Brand Portfolio
1 brands
Stock
NYSE: BDX
Showing Healthcare & Pharmaceuticals brands
1 of 1 total brands
What does BD make?
BD makes medical technology products: needles, syringes, catheters, blood collection systems, infusion pumps, medication dispensing systems, prefillable syringes for drug makers, and surgical and interventional devices.
Is BD publicly traded?
Yes. Becton, Dickinson and Company trades on the NYSE under ticker BDX and is a component of the S&P 500.
Did BD split up?
Yes. On February 9, 2026, BD completed the spin-off of its Biosciences and Diagnostic Solutions business and combined it with Waters Corporation. BD shareholders received approximately 0.135 Waters shares per BDX share, and BD received $4.0 billion in cash.
Who is the CEO of BD?
Tom Polen is Chairman, President, and Chief Executive Officer. He became CEO in January 2020 and chairman in 2021.
What is BD's revenue?
BD reported FY2025 revenue of $21.8 billion (fiscal year ended September 30, 2025), up 8.2% year over year. Post-separation, the continuing business reports on a New BD basis.
Who founded BD?
Maxwell W. Becton and Fairleigh S. Dickinson founded the company in 1897 in New York City. It incorporated in New Jersey in 1906.
No competing brands found in the same categories. This could be because Becton, Dickinson and Companyoperates in unique market segments or we're still building our competitor database.
Becton, Dickinson and Company maintains a diverse portfolio of 1 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Becton, Dickinson and Companyprovides valuable insights into market dynamics, product relationships, and corporate strategy.